Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Human Microbiome market report explains the definition, types, applications, major countries, and major players of the Human Microbiome market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Second Genome
Enterome BioScience
Osel
ActoGeniX
Miomics
Ritter Pharmaceuticals
Vedanta
Rebiotix
Enterologics
Seres Therapeutics
Symberix
MicroBiome Therapeutics LLC
Metabogen
Symbiotix Biotherapies
AvidBiotics
Metabiomics
4D Pharma Research Ltd
By Type:
Gastrointestinal Tract Human Micobiome
Urogenital Tract Human Micobiome
Others
By End-User:
Treatment
Diagnosis
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Human Microbiome Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Human Microbiome Outlook to 2028- Original Forecasts
-
2.2 Human Microbiome Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Human Microbiome Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Human Microbiome Market- Recent Developments
-
6.1 Human Microbiome Market News and Developments
-
6.2 Human Microbiome Market Deals Landscape
7 Human Microbiome Raw Materials and Cost Structure Analysis
-
7.1 Human Microbiome Key Raw Materials
-
7.2 Human Microbiome Price Trend of Key Raw Materials
-
7.3 Human Microbiome Key Suppliers of Raw Materials
-
7.4 Human Microbiome Market Concentration Rate of Raw Materials
-
7.5 Human Microbiome Cost Structure Analysis
-
7.5.1 Human Microbiome Raw Materials Analysis
-
7.5.2 Human Microbiome Labor Cost Analysis
-
7.5.3 Human Microbiome Manufacturing Expenses Analysis
8 Global Human Microbiome Import and Export Analysis (Top 10 Countries)
-
8.1 Global Human Microbiome Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Human Microbiome Export by Region (Top 10 Countries) (2017-2028)
9 Global Human Microbiome Market Outlook by Types and Applications to 2022
-
9.1 Global Human Microbiome Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Gastrointestinal Tract Human Micobiome Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Urogenital Tract Human Micobiome Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Human Microbiome Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Treatment Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Diagnosis Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Human Microbiome Market Analysis and Outlook till 2022
-
10.1 Global Human Microbiome Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Human Microbiome Consumption (2017-2022)
-
10.2.2 Canada Human Microbiome Consumption (2017-2022)
-
10.2.3 Mexico Human Microbiome Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Human Microbiome Consumption (2017-2022)
-
10.3.2 UK Human Microbiome Consumption (2017-2022)
-
10.3.3 Spain Human Microbiome Consumption (2017-2022)
-
10.3.4 Belgium Human Microbiome Consumption (2017-2022)
-
10.3.5 France Human Microbiome Consumption (2017-2022)
-
10.3.6 Italy Human Microbiome Consumption (2017-2022)
-
10.3.7 Denmark Human Microbiome Consumption (2017-2022)
-
10.3.8 Finland Human Microbiome Consumption (2017-2022)
-
10.3.9 Norway Human Microbiome Consumption (2017-2022)
-
10.3.10 Sweden Human Microbiome Consumption (2017-2022)
-
10.3.11 Poland Human Microbiome Consumption (2017-2022)
-
10.3.12 Russia Human Microbiome Consumption (2017-2022)
-
10.3.13 Turkey Human Microbiome Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Human Microbiome Consumption (2017-2022)
-
10.4.2 Japan Human Microbiome Consumption (2017-2022)
-
10.4.3 India Human Microbiome Consumption (2017-2022)
-
10.4.4 South Korea Human Microbiome Consumption (2017-2022)
-
10.4.5 Pakistan Human Microbiome Consumption (2017-2022)
-
10.4.6 Bangladesh Human Microbiome Consumption (2017-2022)
-
10.4.7 Indonesia Human Microbiome Consumption (2017-2022)
-
10.4.8 Thailand Human Microbiome Consumption (2017-2022)
-
10.4.9 Singapore Human Microbiome Consumption (2017-2022)
-
10.4.10 Malaysia Human Microbiome Consumption (2017-2022)
-
10.4.11 Philippines Human Microbiome Consumption (2017-2022)
-
10.4.12 Vietnam Human Microbiome Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Human Microbiome Consumption (2017-2022)
-
10.5.2 Colombia Human Microbiome Consumption (2017-2022)
-
10.5.3 Chile Human Microbiome Consumption (2017-2022)
-
10.5.4 Argentina Human Microbiome Consumption (2017-2022)
-
10.5.5 Venezuela Human Microbiome Consumption (2017-2022)
-
10.5.6 Peru Human Microbiome Consumption (2017-2022)
-
10.5.7 Puerto Rico Human Microbiome Consumption (2017-2022)
-
10.5.8 Ecuador Human Microbiome Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Human Microbiome Consumption (2017-2022)
-
10.6.2 Kuwait Human Microbiome Consumption (2017-2022)
-
10.6.3 Oman Human Microbiome Consumption (2017-2022)
-
10.6.4 Qatar Human Microbiome Consumption (2017-2022)
-
10.6.5 Saudi Arabia Human Microbiome Consumption (2017-2022)
-
10.6.6 United Arab Emirates Human Microbiome Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Human Microbiome Consumption (2017-2022)
-
10.7.2 South Africa Human Microbiome Consumption (2017-2022)
-
10.7.3 Egypt Human Microbiome Consumption (2017-2022)
-
10.7.4 Algeria Human Microbiome Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Human Microbiome Consumption (2017-2022)
-
10.8.2 New Zealand Human Microbiome Consumption (2017-2022)
11 Global Human Microbiome Competitive Analysis
-
11.1 Second Genome
-
11.1.1 Second Genome Company Details
-
11.1.2 Second Genome Human Microbiome Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Second Genome Human Microbiome Main Business and Markets Served
-
11.1.4 Second Genome Human Microbiome Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Enterome BioScience
-
11.2.1 Enterome BioScience Company Details
-
11.2.2 Enterome BioScience Human Microbiome Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Enterome BioScience Human Microbiome Main Business and Markets Served
-
11.2.4 Enterome BioScience Human Microbiome Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Osel
-
11.3.1 Osel Company Details
-
11.3.2 Osel Human Microbiome Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Osel Human Microbiome Main Business and Markets Served
-
11.3.4 Osel Human Microbiome Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 ActoGeniX
-
11.4.1 ActoGeniX Company Details
-
11.4.2 ActoGeniX Human Microbiome Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 ActoGeniX Human Microbiome Main Business and Markets Served
-
11.4.4 ActoGeniX Human Microbiome Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Miomics
-
11.5.1 Miomics Company Details
-
11.5.2 Miomics Human Microbiome Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Miomics Human Microbiome Main Business and Markets Served
-
11.5.4 Miomics Human Microbiome Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Ritter Pharmaceuticals
-
11.6.1 Ritter Pharmaceuticals Company Details
-
11.6.2 Ritter Pharmaceuticals Human Microbiome Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Ritter Pharmaceuticals Human Microbiome Main Business and Markets Served
-
11.6.4 Ritter Pharmaceuticals Human Microbiome Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Vedanta
-
11.7.1 Vedanta Company Details
-
11.7.2 Vedanta Human Microbiome Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Vedanta Human Microbiome Main Business and Markets Served
-
11.7.4 Vedanta Human Microbiome Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Rebiotix
-
11.8.1 Rebiotix Company Details
-
11.8.2 Rebiotix Human Microbiome Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Rebiotix Human Microbiome Main Business and Markets Served
-
11.8.4 Rebiotix Human Microbiome Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Enterologics
-
11.9.1 Enterologics Company Details
-
11.9.2 Enterologics Human Microbiome Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Enterologics Human Microbiome Main Business and Markets Served
-
11.9.4 Enterologics Human Microbiome Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Seres Therapeutics
-
11.10.1 Seres Therapeutics Company Details
-
11.10.2 Seres Therapeutics Human Microbiome Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Seres Therapeutics Human Microbiome Main Business and Markets Served
-
11.10.4 Seres Therapeutics Human Microbiome Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Symberix
-
11.11.1 Symberix Company Details
-
11.11.2 Symberix Human Microbiome Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Symberix Human Microbiome Main Business and Markets Served
-
11.11.4 Symberix Human Microbiome Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 MicroBiome Therapeutics LLC
-
11.12.1 MicroBiome Therapeutics LLC Company Details
-
11.12.2 MicroBiome Therapeutics LLC Human Microbiome Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 MicroBiome Therapeutics LLC Human Microbiome Main Business and Markets Served
-
11.12.4 MicroBiome Therapeutics LLC Human Microbiome Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Metabogen
-
11.13.1 Metabogen Company Details
-
11.13.2 Metabogen Human Microbiome Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Metabogen Human Microbiome Main Business and Markets Served
-
11.13.4 Metabogen Human Microbiome Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Symbiotix Biotherapies
-
11.14.1 Symbiotix Biotherapies Company Details
-
11.14.2 Symbiotix Biotherapies Human Microbiome Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Symbiotix Biotherapies Human Microbiome Main Business and Markets Served
-
11.14.4 Symbiotix Biotherapies Human Microbiome Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 AvidBiotics
-
11.15.1 AvidBiotics Company Details
-
11.15.2 AvidBiotics Human Microbiome Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 AvidBiotics Human Microbiome Main Business and Markets Served
-
11.15.4 AvidBiotics Human Microbiome Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Metabiomics
-
11.16.1 Metabiomics Company Details
-
11.16.2 Metabiomics Human Microbiome Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Metabiomics Human Microbiome Main Business and Markets Served
-
11.16.4 Metabiomics Human Microbiome Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 4D Pharma Research Ltd
-
11.17.1 4D Pharma Research Ltd Company Details
-
11.17.2 4D Pharma Research Ltd Human Microbiome Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 4D Pharma Research Ltd Human Microbiome Main Business and Markets Served
-
11.17.4 4D Pharma Research Ltd Human Microbiome Product Portfolio
-
11.17.5 Recent Research and Development Strategies
12 Global Human Microbiome Market Outlook by Types and Applications to 2028
-
12.1 Global Human Microbiome Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Gastrointestinal Tract Human Micobiome Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Urogenital Tract Human Micobiome Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Human Microbiome Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Treatment Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Diagnosis Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Human Microbiome Market Analysis and Outlook to 2028
-
13.1 Global Human Microbiome Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Human Microbiome Consumption Forecast (2022-2028)
-
13.2.2 Canada Human Microbiome Consumption Forecast (2022-2028)
-
13.2.3 Mexico Human Microbiome Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Human Microbiome Consumption Forecast (2022-2028)
-
13.3.2 UK Human Microbiome Consumption Forecast (2022-2028)
-
13.3.3 Spain Human Microbiome Consumption Forecast (2022-2028)
-
13.3.4 Belgium Human Microbiome Consumption Forecast (2022-2028)
-
13.3.5 France Human Microbiome Consumption Forecast (2022-2028)
-
13.3.6 Italy Human Microbiome Consumption Forecast (2022-2028)
-
13.3.7 Denmark Human Microbiome Consumption Forecast (2022-2028)
-
13.3.8 Finland Human Microbiome Consumption Forecast (2022-2028)
-
13.3.9 Norway Human Microbiome Consumption Forecast (2022-2028)
-
13.3.10 Sweden Human Microbiome Consumption Forecast (2022-2028)
-
13.3.11 Poland Human Microbiome Consumption Forecast (2022-2028)
-
13.3.12 Russia Human Microbiome Consumption Forecast (2022-2028)
-
13.3.13 Turkey Human Microbiome Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Human Microbiome Consumption Forecast (2022-2028)
-
13.4.2 Japan Human Microbiome Consumption Forecast (2022-2028)
-
13.4.3 India Human Microbiome Consumption Forecast (2022-2028)
-
13.4.4 South Korea Human Microbiome Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Human Microbiome Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Human Microbiome Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Human Microbiome Consumption Forecast (2022-2028)
-
13.4.8 Thailand Human Microbiome Consumption Forecast (2022-2028)
-
13.4.9 Singapore Human Microbiome Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Human Microbiome Consumption Forecast (2022-2028)
-
13.4.11 Philippines Human Microbiome Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Human Microbiome Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Human Microbiome Consumption Forecast (2022-2028)
-
13.5.2 Colombia Human Microbiome Consumption Forecast (2022-2028)
-
13.5.3 Chile Human Microbiome Consumption Forecast (2022-2028)
-
13.5.4 Argentina Human Microbiome Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Human Microbiome Consumption Forecast (2022-2028)
-
13.5.6 Peru Human Microbiome Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Human Microbiome Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Human Microbiome Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Human Microbiome Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Human Microbiome Consumption Forecast (2022-2028)
-
13.6.3 Oman Human Microbiome Consumption Forecast (2022-2028)
-
13.6.4 Qatar Human Microbiome Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Human Microbiome Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Human Microbiome Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Human Microbiome Consumption Forecast (2022-2028)
-
13.7.2 South Africa Human Microbiome Consumption Forecast (2022-2028)
-
13.7.3 Egypt Human Microbiome Consumption Forecast (2022-2028)
-
13.7.4 Algeria Human Microbiome Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Human Microbiome Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Human Microbiome Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Human Microbiome
-
Figure of Human Microbiome Picture
-
Table Global Human Microbiome Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Human Microbiome Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Gastrointestinal Tract Human Micobiome Consumption and Growth Rate (2017-2022)
-
Figure Global Urogenital Tract Human Micobiome Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Diagnosis Consumption and Growth Rate (2017-2022)
-
Figure Global Human Microbiome Consumption by Country (2017-2022)
-
Table North America Human Microbiome Consumption by Country (2017-2022)
-
Figure United States Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure Canada Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure Mexico Human Microbiome Consumption and Growth Rate (2017-2022)
-
Table Europe Human Microbiome Consumption by Country (2017-2022)
-
Figure Germany Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure UK Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure Spain Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure Belgium Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure France Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure Italy Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure Denmark Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure Finland Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure Norway Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure Sweden Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure Poland Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure Russia Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure Turkey Human Microbiome Consumption and Growth Rate (2017-2022)
-
Table APAC Human Microbiome Consumption by Country (2017-2022)
-
Figure China Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure Japan Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure India Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure South Korea Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure Thailand Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure Singapore Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure Philippines Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Human Microbiome Consumption and Growth Rate (2017-2022)
-
Table South America Human Microbiome Consumption by Country (2017-2022)
-
Figure Brazil Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure Colombia Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure Chile Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure Argentina Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure Peru Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Human Microbiome Consumption and Growth Rate (2017-2022)
-
Table GCC Human Microbiome Consumption by Country (2017-2022)
-
Figure Bahrain Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure Oman Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure Qatar Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Human Microbiome Consumption and Growth Rate (2017-2022)
-
Table Africa Human Microbiome Consumption by Country (2017-2022)
-
Figure Nigeria Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure South Africa Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure Egypt Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure Algeria Human Microbiome Consumption and Growth Rate (2017-2022)
-
Table Oceania Human Microbiome Consumption by Country (2017-2022)
-
Figure Australia Human Microbiome Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Human Microbiome Consumption and Growth Rate (2017-2022)
-
Table Second Genome Company Details
-
Table Second Genome Human Microbiome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Second Genome Human Microbiome Main Business and Markets Served
-
Table Second Genome Human Microbiome Product Portfolio
-
Table Enterome BioScience Company Details
-
Table Enterome BioScience Human Microbiome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Enterome BioScience Human Microbiome Main Business and Markets Served
-
Table Enterome BioScience Human Microbiome Product Portfolio
-
Table Osel Company Details
-
Table Osel Human Microbiome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Osel Human Microbiome Main Business and Markets Served
-
Table Osel Human Microbiome Product Portfolio
-
Table ActoGeniX Company Details
-
Table ActoGeniX Human Microbiome Sales, Price, Value and Gross Profit (2017-2022)
-
Table ActoGeniX Human Microbiome Main Business and Markets Served
-
Table ActoGeniX Human Microbiome Product Portfolio
-
Table Miomics Company Details
-
Table Miomics Human Microbiome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Miomics Human Microbiome Main Business and Markets Served
-
Table Miomics Human Microbiome Product Portfolio
-
Table Ritter Pharmaceuticals Company Details
-
Table Ritter Pharmaceuticals Human Microbiome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ritter Pharmaceuticals Human Microbiome Main Business and Markets Served
-
Table Ritter Pharmaceuticals Human Microbiome Product Portfolio
-
Table Vedanta Company Details
-
Table Vedanta Human Microbiome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vedanta Human Microbiome Main Business and Markets Served
-
Table Vedanta Human Microbiome Product Portfolio
-
Table Rebiotix Company Details
-
Table Rebiotix Human Microbiome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Rebiotix Human Microbiome Main Business and Markets Served
-
Table Rebiotix Human Microbiome Product Portfolio
-
Table Enterologics Company Details
-
Table Enterologics Human Microbiome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Enterologics Human Microbiome Main Business and Markets Served
-
Table Enterologics Human Microbiome Product Portfolio
-
Table Seres Therapeutics Company Details
-
Table Seres Therapeutics Human Microbiome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Seres Therapeutics Human Microbiome Main Business and Markets Served
-
Table Seres Therapeutics Human Microbiome Product Portfolio
-
Table Symberix Company Details
-
Table Symberix Human Microbiome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Symberix Human Microbiome Main Business and Markets Served
-
Table Symberix Human Microbiome Product Portfolio
-
Table MicroBiome Therapeutics LLC Company Details
-
Table MicroBiome Therapeutics LLC Human Microbiome Sales, Price, Value and Gross Profit (2017-2022)
-
Table MicroBiome Therapeutics LLC Human Microbiome Main Business and Markets Served
-
Table MicroBiome Therapeutics LLC Human Microbiome Product Portfolio
-
Table Metabogen Company Details
-
Table Metabogen Human Microbiome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Metabogen Human Microbiome Main Business and Markets Served
-
Table Metabogen Human Microbiome Product Portfolio
-
Table Symbiotix Biotherapies Company Details
-
Table Symbiotix Biotherapies Human Microbiome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Symbiotix Biotherapies Human Microbiome Main Business and Markets Served
-
Table Symbiotix Biotherapies Human Microbiome Product Portfolio
-
Table AvidBiotics Company Details
-
Table AvidBiotics Human Microbiome Sales, Price, Value and Gross Profit (2017-2022)
-
Table AvidBiotics Human Microbiome Main Business and Markets Served
-
Table AvidBiotics Human Microbiome Product Portfolio
-
Table Metabiomics Company Details
-
Table Metabiomics Human Microbiome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Metabiomics Human Microbiome Main Business and Markets Served
-
Table Metabiomics Human Microbiome Product Portfolio
-
Table 4D Pharma Research Ltd Company Details
-
Table 4D Pharma Research Ltd Human Microbiome Sales, Price, Value and Gross Profit (2017-2022)
-
Table 4D Pharma Research Ltd Human Microbiome Main Business and Markets Served
-
Table 4D Pharma Research Ltd Human Microbiome Product Portfolio
-
Figure Global Gastrointestinal Tract Human Micobiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Urogenital Tract Human Micobiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diagnosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Human Microbiome Consumption Forecast by Country (2022-2028)
-
Table North America Human Microbiome Consumption Forecast by Country (2022-2028)
-
Figure United States Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Human Microbiome Consumption Forecast by Country (2022-2028)
-
Figure Germany Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Human Microbiome Consumption Forecast by Country (2022-2028)
-
Figure China Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Human Microbiome Consumption Forecast by Country (2022-2028)
-
Figure Brazil Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Human Microbiome Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Human Microbiome Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Human Microbiome Consumption Forecast by Country (2022-2028)
-
Figure Australia Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Human Microbiome Consumption Forecast and Growth Rate (2022-2028)
-
